Mesoblast
MESO
31 hedge funds and large institutions have $1.59M invested in Mesoblast in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 11 closing their positions.
81% more call options, than puts
Call options by funds: $705K | Put options by funds: $390K
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
0.01% less ownership
Funds ownership: 0.08% → 0.07% (-0.01%)
2% less capital invested
Capital invested by funds: $1.63M → $1.59M (-$37.5K)
11% less funds holding
Funds holding: 35 → 31 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$263K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$159K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$113K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$75.6K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$23.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$91.3K |
| 2 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
-$78.9K |
| 3 |
VF
Virtu Financial
New York
|
-$76K |
| 4 |
Jane Street
New York
|
-$49K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$42K |
MESO Hedge Fund Activity: Q4 2023 in Review
31 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2023, worth a combined $1.59M — down 2.3% from $1.63M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of MESO and 7 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Morgan Stanley, adding an estimated $263K. The largest seller was Simplex Trading, exiting entirely with an estimated $91.3K sold.
- 31 institutional investors held Mesoblast (MESO) as of Q4 2023, down from 35 in Q3 2023.
- Funds reported $1.59M of Mesoblast stock for Q4 2023, down 2.3% quarter-over-quarter.
- 7 funds opened new Mesoblast positions in Q4 2023 and 11 closed out, a net change of -4 holders.
- The largest Mesoblast buyer in Q4 2023 was Morgan Stanley, an estimated $263K added.
- The largest Mesoblast seller in Q4 2023 was Simplex Trading, an estimated $91.3K sold.
Based on aggregated 13F filings for Q4 2023.